Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer

D. J. Fitzgerald, M. J. Bjorn, R. J. Ferris, J. L. Winkelhake, A. E. Frankel, T. C. Hamilton, R. F. Ozols, M. C. Willingham, I. Pastan

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

An immunotoxin composed of an antibody to the human transferrin receptor (454A12) and ricin A chain (RTA) was shown to inhibit the growth of NIH:OVCAR-3 tumors in a nude mouse model of human ovarian cancer. Inhibition of tumor growth by 454A12-RTA was related to the dose administered. The antitumor activity of the immunotoxin was blocked by coinjection of excess antibody with immunotoxin. An immunotoxin made using 454A12 and recombinant ricin A chain (rRTA) had an activity similar to that made with native RTA. The administration of 10 μg or greater of the immunotoxin 454A12-RTA/rRTA had significant antitumor activity. The injection of 30 μg of an irrelevant immunotoxin, MOPC21-RTA, or 30 to 500 μg of the 454A12 antibody had no antitumor activity.

Original languageEnglish (US)
Pages (from-to)1407-1410
Number of pages4
JournalCancer Research
Volume47
Issue number5
StatePublished - 1987

Fingerprint

Immunotoxins
Nude Mice
Ovarian Neoplasms
Ricin
Antibodies
Transferrin Receptors
Growth
Neoplasms
Injections

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Fitzgerald, D. J., Bjorn, M. J., Ferris, R. J., Winkelhake, J. L., Frankel, A. E., Hamilton, T. C., ... Pastan, I. (1987). Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer. Cancer Research, 47(5), 1407-1410.

Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer. / Fitzgerald, D. J.; Bjorn, M. J.; Ferris, R. J.; Winkelhake, J. L.; Frankel, A. E.; Hamilton, T. C.; Ozols, R. F.; Willingham, M. C.; Pastan, I.

In: Cancer Research, Vol. 47, No. 5, 1987, p. 1407-1410.

Research output: Contribution to journalArticle

Fitzgerald, DJ, Bjorn, MJ, Ferris, RJ, Winkelhake, JL, Frankel, AE, Hamilton, TC, Ozols, RF, Willingham, MC & Pastan, I 1987, 'Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer', Cancer Research, vol. 47, no. 5, pp. 1407-1410.
Fitzgerald DJ, Bjorn MJ, Ferris RJ, Winkelhake JL, Frankel AE, Hamilton TC et al. Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer. Cancer Research. 1987;47(5):1407-1410.
Fitzgerald, D. J. ; Bjorn, M. J. ; Ferris, R. J. ; Winkelhake, J. L. ; Frankel, A. E. ; Hamilton, T. C. ; Ozols, R. F. ; Willingham, M. C. ; Pastan, I. / Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer. In: Cancer Research. 1987 ; Vol. 47, No. 5. pp. 1407-1410.
@article{2bb163d974ba492ea183307ae17aa001,
title = "Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer",
abstract = "An immunotoxin composed of an antibody to the human transferrin receptor (454A12) and ricin A chain (RTA) was shown to inhibit the growth of NIH:OVCAR-3 tumors in a nude mouse model of human ovarian cancer. Inhibition of tumor growth by 454A12-RTA was related to the dose administered. The antitumor activity of the immunotoxin was blocked by coinjection of excess antibody with immunotoxin. An immunotoxin made using 454A12 and recombinant ricin A chain (rRTA) had an activity similar to that made with native RTA. The administration of 10 μg or greater of the immunotoxin 454A12-RTA/rRTA had significant antitumor activity. The injection of 30 μg of an irrelevant immunotoxin, MOPC21-RTA, or 30 to 500 μg of the 454A12 antibody had no antitumor activity.",
author = "Fitzgerald, {D. J.} and Bjorn, {M. J.} and Ferris, {R. J.} and Winkelhake, {J. L.} and Frankel, {A. E.} and Hamilton, {T. C.} and Ozols, {R. F.} and Willingham, {M. C.} and I. Pastan",
year = "1987",
language = "English (US)",
volume = "47",
pages = "1407--1410",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer

AU - Fitzgerald, D. J.

AU - Bjorn, M. J.

AU - Ferris, R. J.

AU - Winkelhake, J. L.

AU - Frankel, A. E.

AU - Hamilton, T. C.

AU - Ozols, R. F.

AU - Willingham, M. C.

AU - Pastan, I.

PY - 1987

Y1 - 1987

N2 - An immunotoxin composed of an antibody to the human transferrin receptor (454A12) and ricin A chain (RTA) was shown to inhibit the growth of NIH:OVCAR-3 tumors in a nude mouse model of human ovarian cancer. Inhibition of tumor growth by 454A12-RTA was related to the dose administered. The antitumor activity of the immunotoxin was blocked by coinjection of excess antibody with immunotoxin. An immunotoxin made using 454A12 and recombinant ricin A chain (rRTA) had an activity similar to that made with native RTA. The administration of 10 μg or greater of the immunotoxin 454A12-RTA/rRTA had significant antitumor activity. The injection of 30 μg of an irrelevant immunotoxin, MOPC21-RTA, or 30 to 500 μg of the 454A12 antibody had no antitumor activity.

AB - An immunotoxin composed of an antibody to the human transferrin receptor (454A12) and ricin A chain (RTA) was shown to inhibit the growth of NIH:OVCAR-3 tumors in a nude mouse model of human ovarian cancer. Inhibition of tumor growth by 454A12-RTA was related to the dose administered. The antitumor activity of the immunotoxin was blocked by coinjection of excess antibody with immunotoxin. An immunotoxin made using 454A12 and recombinant ricin A chain (rRTA) had an activity similar to that made with native RTA. The administration of 10 μg or greater of the immunotoxin 454A12-RTA/rRTA had significant antitumor activity. The injection of 30 μg of an irrelevant immunotoxin, MOPC21-RTA, or 30 to 500 μg of the 454A12 antibody had no antitumor activity.

UR - http://www.scopus.com/inward/record.url?scp=0023125216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023125216&partnerID=8YFLogxK

M3 - Article

C2 - 3493065

AN - SCOPUS:0023125216

VL - 47

SP - 1407

EP - 1410

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 5

ER -